These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


198 related items for PubMed ID: 16697772

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Impaired release of natural killer cytotoxic factor in patients with primary Sjögren's syndrome.
    Pedersen BK, Oxholm P.
    Clin Exp Immunol; 1988 May; 72(2):299-302. PubMed ID: 3409548
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Correlation of increased susceptibility to apoptosis of CD4+ T cells with lymphocyte activation and activity of disease in patients with primary Sjögren's syndrome.
    Zeher M, Szodoray P, Gyimesi E, Szondy Z.
    Arthritis Rheum; 1999 Aug; 42(8):1673-81. PubMed ID: 10446867
    [Abstract] [Full Text] [Related]

  • 10. A significantly impaired natural killer cell activity due to a low activity on a per-cell basis in rheumatoid arthritis.
    Aramaki T, Ida H, Izumi Y, Fujikawa K, Huang M, Arima K, Tamai M, Kamachi M, Nakamura H, Kawakami A, Origuchi T, Matsuoka N, Eguchi K.
    Mod Rheumatol; 2009 Aug; 19(3):245-52. PubMed ID: 19283441
    [Abstract] [Full Text] [Related]

  • 11. [Cell-mediated immunity in patients with Sjogren's syndrome].
    Krejsek J, Slezák R, Kopecký O, Vokurková D, Loudová M, Derner V.
    Cas Lek Cesk; 1997 Jan 22; 136(2):44-7. PubMed ID: 9147852
    [Abstract] [Full Text] [Related]

  • 12. Up-regulation of NK cell activating receptors following allogeneic hematopoietic stem cell transplantation under a lymphodepleting reduced intensity regimen is associated with elevated IL-15 levels.
    Boyiadzis M, Memon S, Carson J, Allen K, Szczepanski MJ, Vance BA, Dean R, Bishop MR, Gress RE, Hakim FT.
    Biol Blood Marrow Transplant; 2008 Mar 22; 14(3):290-300. PubMed ID: 18275895
    [Abstract] [Full Text] [Related]

  • 13. Ex vivo CD(+) T-cell cytokine expression from patients with Sjögren's syndrome following in vitro stimulation to induce proliferation.
    Koarada S, Haruta Y, Mitamura M, Morito F, Tada Y, Ohta A, Nagasawa K.
    Rheumatology (Oxford); 2006 Apr 22; 45(4):392-9. PubMed ID: 16287915
    [Abstract] [Full Text] [Related]

  • 14. Sjögren's syndrome with myalgia is associated with subnormal secretion of cytokines by peripheral blood mononuclear cells.
    Eriksson P, Andersson C, Ekerfelt C, Ernerudh J, Skogh T.
    J Rheumatol; 2004 Apr 22; 31(4):729-35. PubMed ID: 15088299
    [Abstract] [Full Text] [Related]

  • 15. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
    Guo KY, Mei JZ, Yao KT.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar 22; 27(3):247-9. PubMed ID: 17425963
    [Abstract] [Full Text] [Related]

  • 16. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.
    El-Sherbiny YM, Meade JL, Holmes TD, McGonagle D, Mackie SL, Morgan AW, Cook G, Feyler S, Richards SJ, Davies FE, Morgan GJ, Cook GP.
    Cancer Res; 2007 Sep 15; 67(18):8444-9. PubMed ID: 17875681
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans.
    Shen L, Suresh L, Li H, Zhang C, Kumar V, Pankewycz O, Ambrus JL.
    Clin Immunol; 2009 Mar 15; 130(3):304-12. PubMed ID: 19038581
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Minor salivary gland immunohistology in the diagnosis of primary Sjögren's syndrome.
    Salomonsson S, Rozell BL, Heimburger M, Wahren-Herlenius M.
    J Oral Pathol Med; 2009 Mar 15; 38(3):282-8. PubMed ID: 18793250
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.